ABSTRACT Bronchial responsiveness to inhaled histamine was measured two, seven, and 30 hours after allergen inhalation challenge in 19 atopic subjects. The provocative histamine concentrations causing a 20% fall in FEV, (PC20) at these three times were compared with the baseline value, with values obtained two and seven hours after diluent inhalation, and with those obtained five to seven days after allergen challenge in the 12 late responders. Seven subjects had allergen induced isolated early asthmatic responses (1 FEV, 22 6% (SD 6 6%)) with less than a 5% late fall in FEV,. There was no change in the six histamine PC20 values measured in these seven subjects; the geometric mean PC20was 10-1 3mg/ml on all six occasions. Twelve subjects had an allergen induced early asthmatic response (AFEV, 26 3% (9 8%)) followed by a definite (> 15% JAFEV1, n = 7) or equivocal (5-15% A FEV,, n = 5) late asthmatic response. The geometric mean histamine PC20 was not significantly different two hours after allergen inhalation either from baseline (0-67 v 0 78 mg/ml) or from that seen two hours after diluent (0 67 v 0 95). It was significantly reduced at seven (0 24 mg/ml) and at 30 hours (0 44 mg/ml) but had returned to baseline when repeated five to seven days later (0-74 mg/ml). In 10 subjects with a dual response who had a repeat antigen challenge the mean early and late response and A PC20 at seven and 30 hours were similar. These data show that bronchial responsiveness to a non-allergic stimulus has not increased two hours after allergen inhalation following spontaneous recovery of the early asthmatic response but before the start of the late asthmatic response.
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Non-allergic bronchial responsiveness (for example, to inhaled histamine or methacholine) may increase after exposure to allergen'3 or occupational sensitising agents4 5 in a sensitised individual. There is a close relationship between allergen or occupational induced increase in non-allergic bronchial responsiveness and the late asthmatic response. '-5 Non-allergic bronchial responsiveness does not appear to increase after isolated early asthmatic responses.' 3 Bronchial responsiveness to histamine or methacholine is increased seven to eight hours after allergen challenge' 24 towards the end of the late response and this may persist for days after the late response, at a time when all measurements of lung function have returned to baseline. 1 2 4 our knowledge, change in bronchial responsiveness in the inter-val phase between the early and the late response to allergen has not been examined closely. In this study we measured bronchial responsiveness to histamine before and two, seven, and 30 hours after allergen inhalation in 19 subjects undergoing controlled allergen inhalation tests.
Methods

SUBJECTS
Nineteen subjects were selected from volunteers and patients at the respiratory clinic, University Hospital, Saskatoon. All subjects had asthma, defined as wheezing dyspnoea on exposure to an allergen to which they had a positive prick skin test response. All subjects were atopic and had an FEV, greater than 70% of the predicted value and a histamine provocative concentration causing a 20% fall in FEV5 (PC20) of 10 mg/ml or less. They were using no medication other than an inhaled /32 agonist occasionally as needed (n = 7). The investigations were approved Changes in bronchial responsiveness to histamine at intervals after allergen challenge Allergent   respon   I  19  M  188  90 9  5 2  109  8 0  Horse  E  2  18  F  160  59 0  3 1  96  6 8  Cat  E   3  22  M  173  80 5  4 7  108  5 4  Grass  D  4  19  F  175  86.4  4 1  110  3-8  Cat  D  S5  17  F  160  645  36  110  38  Grass  D  6  23  F  165  52 7  3 5  106  2 5  Horse  E  7  27  F  160  84 1  3 0  101  2.1  Grass  D  8  28  F  165  745  37  117  12  Cat  D  9  22  M  180  81 8  4 2  92 , and 7 hours after the final inhalation. The best FEV1 at each time was retained for analysis. Histamine PC20 and the allergen concentration required to produce a 2 mm skin weal were determined during day 1 and these allowed prediction of the allergen PC20.9 On day 2, usually the next morning, allergen inhalation was performed. In a fashion analogous to diluent inhalation, doubling amounts of the relevant aqueous allergen, beginning three dilutions below the predicted allergen PC20, were inhaled for two minutes at 10 minute intervals until the FEV1 had fallen at least 20%; the FEV1 was then followed for seven hours as on day 1. The percentage fall in FEV1 was calculated from the highest baseline to the highest post-allergen FEV1.
STUDY DESIGN
Subjects attended the laboratory on two days (which were usually consecutive) for control and allergen inhalation tests. All had a stable FEV1 (t< 10% difference between the two days), none had suffered 304 Cockcroft, Murdock allergen exposure or respiratory tract infection for at least four weeks, and all were able to withhold inhaled f2 agonists for at least eight hours.
Histamine PC20 was measured six or seven times in all subjects. A baseline PC20 was obtained within two weeks of the study. Histamine inhalation was repeated, starting two and seven hours after completion of diluent inhalation on day 1 and two, seven, and 30 hours after allergen inhalation on day 2. In all cases the two hour histamine inhalation test was completed in less than 30 minutes and was therefore completed 2 25-2 5 hours after allergen inhalation. In subjects with a late asthmatic response and a significant reduction in histamine PC20 a seventh histamine inhalation test was done five to seven days later.
Ten subjects with equivocal or definite dual asthmatic responses underwent repeat allergen challenge within two months of the original study. subject. This subject was included because he had a reproducible late response with an associated fall in histamine PC20. The mean late fall in FEV1 was 11-8% (10-9%) (p < 0-001). There was a definite late response (> 15%) in seven subjects, an equivocal late response (5-15%) in five, and no late response (< 5%) in seven subjects.
CHANGES IN HISTAMINE PC20 AFTER ALLERGEN
CHALLENGE
Changes in histamine PC20 seven and 30 hours after allergen challenge were compared with those occurring seven hours after saline and with prior "baseline" measurements in all 19 subjects (table 2) . Geometric mean histamine PC20 values were 0 93 mg/ml at baseline, 0 95 mg/ml seven hours after saline, 0 42 mg/ml seven hours after allergen, and 0 70 mg/ml (n = 18) 30 hours after allergen. Mean and SD log histamine PC20 values are shown in table 2. The values seven and 30 hours after allergen were significantly lower than those seven hours after saline (p < 0 001 and p = 0-01 respectively). In six of the seven subjects with an isolated early response there was less than a twofold reduction in PC20 at both seven and 30 hours after allergen compared with seven hours after saline. On the other hand, all 12 subjects with either a definite or an equivocal late response showed a greater than twofold reduction in PC20 at either seven hours (n = 10) or 30 hours (n = 6) following allergen. Despite a trend for larger falls in histamine PC20 with larger late responses to allergen there was no significant correlation in this study, nor was there any difference between mean A log PC20 in the seven definite and five equivocal late responders. The FEV, was reduced by 13 7% (SD 10%) (p < 0 001) and the histamine PC20 was reduced almost fourfold to 0.24 mg/ml (p < 0 001). At 30 hours the FEV1 was back to baseline but the PC20 was still reduced almost twofold to 0A44mg/ml (p < 0 01). Changes in FEV, and histamine PC20 in subjects with a dual response are shown in figure 2.
REPEAT ANTIGEN STUDIES
In the 10 dual responders undergoing a repeat antigen challenge the repeat values for the early response (30 2% (SD 15 8%) v 26 3% (9 8%)), late response (218% (13-6%) v 174% (105%)), zllog PC20 at seven hours (0 58 (0 36) v 0 55 (0 31)), and Alog PC20 at 30 hours (0 32 (0-16) v 0-31 (0-15)) were reproducible. This suggests that the performance of a histamine test two hours after allergen challenge did not affect the subsequent development (or magnitude) of the late response, or change histamine responsiveness.
Discussion
These data show that non-allergic bronchial responsiveness to histamine had not increased when measured 2-2 5 hours after allergen exposure in nine of 12 subjects with subsequent allergen induced late responses. The three subjects who had a fall in histamine PC20 slightly more than twofold did not have unusually large (12%, 22%, and 24%) or unusually early late responses. Non-allergic bronchial responsiveness to histamine and cholinergic agonists has been shown to increase after both natural3 [11] [12] [13] [14] Cockcroft, Murdock hours after allergen exposure. It is therefore not surprising that significant changes may have occurred by three hours. In fact, the observation of probably significant falls in histamine PC20 in three of our 12 subjects at two hours supports the idea that increased responsiveness may develop between two and three to four hours after exposure, which is before the late response occurs. The studies in occupational asthma'6 may not, however, be entirely analogous. The immunopathology of many of these remains somewhat obscure and the late or non-immediate asthmatic responses are more common, may begin earlier, and may last longer than those that follow allergen exposure. 17 18 Both the late responses and the changes in bronchial responsiveness to histamine were substantially smaller in this study than in previous studies.' 2 Previous observations suggest that more severe late responses start earlier and last longer. Possibly therefore more severe late asthmatic responses are associated with earlier changes in histamine responsiveness. Such a trend was not observed in our study. The most severe late responses, 40% and 32% falls in FEV1, were not associated with an early change in PC20; while the three subjects with a greater than twofold fall in PC20 two hours after allergen did not have particularly large late responses (12%, 22%, and 24%). In two of these three subjects the greater than twofold PC20 difference from the value two hours after diluent was due to an unexpected high PC20 value after diluent; neither showed a twofold change when the two hour value was compared with the baseline determination.
The precise pathophysiology of the late asthmatic response and associated transient increases in airways responsiveness remains uncertain. Early speculation that a type III immune response played a part ' 
